Investing money in shares of X-ray security specialist American Science & Engineering is always an exercise in guesswork. The company famously refuses to provide guidance on what it might earn in any future quarter (or even year), requiring investors to evaluate the stock on what it's done, rather than what it promises to do.
Continue Reading Below
That's not necessarily a bad thing. But for better or for worse, it makes every earnings report feel a little bit like Christmas. You really have no idea what's going to be inside the box till you've untied the ribbon, ripped off the wrapping paper, and looked inside. So let's do that.
Good news from AS&EAmerican Science & Engineering (habitually referred to as AS&E because its name is just so darn long) reported financial results for its fiscal second quarter 2016 on Monday. Analysts had predicted that AS&E would deliver $0.08 per share in profits and $25.1 million in revenues for Q2, and surprisingly, they hit pretty close to the mark this time:
- Q2 sales were in fact $25.1 million, and thus 9% better than last year's Q2.
- Operating profits of $831,000 were only 3.3% of revenues, but still a big improvement over last year's Q2 operating loss.
- Concentrated among fewer shares outstanding, and after taxes, this left AS&E with $0.06 per share in net profit on the bottom line.
Now, obviously, $0.06 wasn't as good as the $0.08 that Wall Street had been expecting. But given that AS&E gave the Street analysts little help in working up their estimates, and considering that last year, AS&E's Q2 results featured a $0.49-per-share loss, investors took the news of the "earnings miss" in stride. Shares are now trading up more than 2% from pre-earnings levels, even as the broader stock market continues to be in the red.
Also working in AS&E's stock's favor this week is the company's report that it generated $8.7 million in positive free cash flow in Q2. Year to date, that puts FCF at $2.6 million (versus $26.9 million in cash burn through H1 of fiscal 2015). What's more, if you add up cash produced in this year's H1 and last year's H2, the company has now piled up about $15.8 million in positive free cash flow over the past 12 months.
ValuationIs that enough cash to make the stock a "buy"? Perhaps.
Divided into the stock's $291 million market cap, AS&E stock now sells for about 18.4 times FCF. That's a whole lot cheaper-seeming than the stock's P/E ratio, which currently stands at... 85.5. Analysts (again, working off only minimal guidance, so take this with a grain of salt) on S&P Capital IQ predict that AS&E will continue growing its profits at about 14% annually over the next five years, and AS&E currently yields a generous 5.1% dividend on its stock.
Given all this, I'd have to say that 18.4 times FCF actually does look like a pretty good price to pay. The more so when you recall that debt-free AS&E has more than $82 million cash in the bank, which has the effect of making the stock even cheaper when valued on its enterprise value (for anyone interested, the EV/FCF ratio works out to just 11.4).
Long story short, as long as AS&E keeps the cash flowing, it looks like a good bet to me.
The article American Science & Engineering Stock: Is It a Cash Monster? originally appeared on Fool.com.
Rich Smithdoes not own shares of, nor is he short, any company named above. You can find him onMotley Fool CAPS, publicly pontificating under the handleTMFDitty, where he's currently ranked No. 299 out of more than 75,000 rated members.The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright 1995 - 2015 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.